SC 13G | 2021-02-05 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 6.3% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 16,259,745 | 9.2% | EDGAR |
SC 13G | 2021-01-25 | Sarissa Capital Management LP | BIOCRYST PHARMACEUTICALS INC | 8,844,000 | 5.0% | EDGAR |
SC 13G/A | 2020-12-10 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 10.2% | EDGAR |
SC 13G | 2020-06-10 | CITADEL ADVISORS LLC | BIOCRYST PHARMACEUTICALS INC | - | 4.8% | EDGAR |
SC 13G | 2020-04-17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | BIOCRYST PHARMACEUTICALS INC | 2,500,000 | 1.6% | EDGAR |
SC 13G/A | 2020-02-14 | Point72 Asset Management, L.P. | BIOCRYST PHARMACEUTICALS INC | 8,382,900 | 5.4% | EDGAR |
SC 13G/A | 2020-02-14 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 15,797,212 | 9.9% | EDGAR |
SC 13G/A | 2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | BIOCRYST PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-13 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 6,375,143 | 4.1% | EDGAR |
SC 13G/A | 2020-02-13 | JANUS HENDERSON GROUP PLC | BIOCRYST PHARMACEUTICALS INC | 9,408,481 | 8.5% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 8,121,631 | 5.3% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 12,150,211 | 7.9% | EDGAR |
SC 13G/A | 2020-01-22 | INTEGRATED CORE STRATEGIES (US) LLC | BIOCRYST PHARMACEUTICALS INC | 6,899,443 | 4.5% | EDGAR |
SC 13G | 2019-11-19 | Point72 Asset Management, L.P. | BIOCRYST PHARMACEUTICALS INC | 9,300,000 | 6.0% | EDGAR |
SC 13G | 2019-05-29 | INTEGRATED CORE STRATEGIES (US) LLC | BIOCRYST PHARMACEUTICALS INC | 6,125,550 | 5.6% | EDGAR |
SC 13G/A | 2019-02-14 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 10,660,349 | 9.7% | EDGAR |
SC 13G | 2019-02-14 | Venrock Healthcare Capital Partners II, L.P. | BIOCRYST PHARMACEUTICALS INC | 6,310,255 | 5.8% | EDGAR |
SC 13G/A | 2019-02-13 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 15,148,081 | 13.8% | EDGAR |